Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Change in Inventory (2016 - 2025)

Mimedx's Change in Inventory history spans 15 years, with the latest figure at -$1.2 million for Q4 2025.

  • For Q4 2025, Change in Inventory fell 164.09% year-over-year to -$1.2 million; the TTM value through Dec 2025 reached $1.5 million, down 34.96%, while the annual FY2025 figure was $1.5 million, 34.96% down from the prior year.
  • Change in Inventory for Q4 2025 was -$1.2 million at Mimedx, down from $1.6 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $2.9 million in Q1 2024 and bottomed at -$1.4 million in Q2 2021.
  • The 5-year median for Change in Inventory is $741500.0 (2024), against an average of $746400.0.
  • The largest annual shift saw Change in Inventory tumbled 238.7% in 2022 before it skyrocketed 918.4% in 2023.
  • A 5-year view of Change in Inventory shows it stood at $571000.0 in 2021, then crashed by 238.7% to -$792000.0 in 2022, then surged by 346.59% to $2.0 million in 2023, then tumbled by 122.53% to -$440000.0 in 2024, then crashed by 164.09% to -$1.2 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Change in Inventory are -$1.2 million (Q4 2025), $1.6 million (Q3 2025), and $820000.0 (Q2 2025).